# Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes

> **NCT00668616** · PHASE3 · COMPLETED · sponsor: **North Eastern German Society of Gynaecological Oncology** · enrollment: 1034 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Cyclophosphamide, Epirubicin, Paclitaxel
- **DRUG:** Epirubicin, Paclitaxel, Filgrastim

## Key facts

- **NCT ID:** NCT00668616
- **Lead sponsor:** North Eastern German Society of Gynaecological Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2005-07
- **Final completion:** 2009-07
- **Target enrollment:** 1034 (ACTUAL)
- **Last updated:** 2010-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668616, "Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00668616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*